ArticlebioRxiv : the preprint server for biology2026
Origins of allostery in vertebrate hemoglobin evolution.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Allostery-regulation of a protein's activity by binding to an effector-is an essential functional feature of many proteins. Its structural basis is complex: a protein must bind effector at one site-an interaction that typically involves many complementary residues-and this binding event must change the protein's conformation at the distant active site. How allosteric proteins evolved this architecture is unknown because there are no cases in which the historical mechanisms by which allostery was acquired from nonallosteric precursors have been identified. Vertebrate hemoglobin (Hb) is a tetrameric protein whose oxygen affinity is reduced by binding organic phosphates. We used ancestral protein reconstruction, biochemical experiments, and in silico studies of protein structure and dynamics to identify the changes in protein sequence and structure that caused allosteric Hb to evolve from its non-allosteric dimeric precursor. We found that just two historical substitutions were sufficient to confer positive allostery on the ancestor-one that caused the dimer to tetramerize, and another that created an effector binding site in the tetramer's central cavity. Two additional substitutions changed the effector's position and conferred the modern form of negative allostery. This short evolutionary path to allostery was possible because most of the key requirements for allostery already existed as by-products of the protein's structure: the tertiary transition between oxygenated and deoxygenated conformations is an ancient and intrinsic property of the globin fold. It affects the surface patch that ultimately mediated tetramer assembly, so as soon as tetramerization evolved because of one substitution on that surface, tertiary heterogeneity propagated to large-scale quaternary heterogeneity. The other substitution(s) conferred effector binding at a site within the tetramer that is preferentially accessible in the deoxygenated state. One of the most complex and essential protein phenomena therefore evolved via simple and intelligible mechanisms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.